GSK To Put Up To $7.2B Into Biotech VC’s Pipeline

0
102

Biondi stated the collaboration is part of the venture capital company’s “Innovation Supply Chain Partnership model,” developed to create and develop breakthrough medicines by forming strategic partnerships with pharmaceutical companies.